Drug survival of dupilumab, tralokinumab and upadacitinib in patients with atopic dermatitis: An international, real-world comparative study

被引：1

作者：

Torres, Tiago ^{[1
,2
]}

Yeung, Jensen ^{[3
,4
,5
,6
]}

Prajapati, Vimal ^{[7
,8
,9
,10
]}

Ribero, Simone ^{[11
]}

Balato, Anna ^{[12
]}

Valerio Marzano, Angelo ^{[13
,14
]}

Cruz, Maria Joao ^{[15
,16
]}

Paiva Lopes, Maria Joao ^{[17
]}

Lazaridou, Elizabeth ^{[18
]}

Carrascosa, Jose-Manuel ^{[19
]}

Alvarenga, Jose Miguel ^{[1
]}

Farinha, Pedro ^{[17
]}

Duarte, Bruno ^{[17
]}

Sood, Siddhartha ^{[20
]}

Rankin, Brian D. ^{[7
]}

Ortoncelli, Michela ^{[11
]}

Caccavale, Stefano ^{[12
]}

Ferrucci, Silvia Mariel ^{[13
]}

Rosa, Gilberto Pires ^{[15
,16
]}

Daponte, Athina Ioanna ^{[18
]}

Silvi, Gianmarco ^{[21
]}

Peris, Ketty ^{[22
,23
]}

Gori, Niccolo ^{[22
,23
]}

Herranz, Pedro ^{[19
]}

Prignano, Francesca ^{[21
]}

Kolios, Antonio ^{[24
,25
]}

Rompoti, Natalia ^{[26
,27
]}

Gkalpakiotis, Spyridon ^{[26
,27
]}

Chiricozzi, Andrea ^{[22
,23
]}

机构：

[1] Ctr Hosp Univ Santo Antonio Porto, Dept Dermatol, Porto, Portugal

[2] Univ Porto, Inst Ciencias Biomed Abel Salazar, Porto, Portugal

[3] Univ Toronto, Dept Med, Div Dermatol, Toronto, ON, Canada

[4] Womens Coll Hosp, Dept Med, Div Dermatol, Toronto, ON, Canada

[5] Sunnybrook Hlth Sci Ctr, Dept Med, Div Dermatol, Toronto, ON, Canada

[6] Prob Med Res, Toronto, ON, Canada

[7] Univ Calgary, Dept Med, Div Dermatol, Calgary, AB, Canada

[8] Dermatol Res Inst, Calgary, AB, Canada

[9] Skin Hlth & Wellness Ctr, Calgary, AB, Canada

[10] Prob Med Res, Calgary, AB, Canada

[11] Univ Turin, Dept Med Sci, Dermatol Clin, Turin, Italy

[12] Univ Campania Luigi Vanvitelli, Unit Dermatol, Naples, Italy

[13] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dermatol Unit, Milan, Italy

[14] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy

[15] Unidade Local Saude Sao Joao, Dept Dermatol, Porto, Portugal

[16] Univ Porto, Fac Med, Porto, Portugal

[17] Ctr Hosp Univ Lisboa Cent, Neurol Dept, Lisbon, Portugal

[18] Aristotle Univ Thessaloniki, Dept Dermatol & Venereol, Sch Med, Thessaloniki, Greece

[19] Hosp Univ Germans Trias i Pujol, Barcelona, Spain

[20] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada

[21] Univ Florence, Dept Hlth Sci, Dermatol Sect, Florence, Italy

[22] Univ Cattolica Sacro Cuore, Dipartimento Univ Med & Chirurg Traslaz, Dermatol, Rome, Italy

[23] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Med & Chirurg, UOC Dermatol, Rome, Italy

[24] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA USA

[25] Univ Hosp Bern, Dept Dermatol, Inselspital, Bern, Switzerland

[26] Charles Univ Prague, Univ Hosp Kralovske Vinohrady, Fac Med 3, Stare Mesto, Czech Republic

[27] Charles Univ Prague, Fac Med 3, Stare Mesto, Czech Republic

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2025年

关键词：

D O I：

10.1111/jdv.20581

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页数：6

共 50 条

[31] Real-world efficacy and safety of dupilumab for paediatric atopic dermatitis: a multicentre retrospective study
Pirov, Eitan
Molho-Pessach, Vered
Cohen-Barak, Eran
Levitt, Jen A. Barak
Barzilai, Aviv
Bar, Jonathan
Renert-Yuval, Yael
Bar-Ilan, Efrat
Friedland, Rivka
Greenberger, Shoshana
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024,
[32] Drug survival analysis of dupilumab and cyclosporin in patients with atopic dermatitis: a multicenter study
Napolitano, Maddalena
Mariano, Maria
Cristaudo, Antonio
Dastoli, Stefano
Di Guida, Adriana
De Lucia, Mario
Guerrasio, Gianluca
Nistico, Steven Paul
Passante, Maria
Pigliacelli, Flavia
Fabbrocini, Gabriella
Patruno, Cataldo
JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (05) : 2670 - 2673
[33] Drug survival rate of dupilumab in Japanese patients with atopic dermatitis
Ichiyama, Susumu
Ito, Michiko
Hoashi, Toshihiko
Kanda, Naoko
Saeki, Hidehisa
JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2021, 4 (05) : 151 - 152
[34] Real-World Experience of Upadacitinib Dosing Reduction in Patients with Moderate Atopic Dermatitis: A Case Series Study in Taiwan
Chen, Yang-Yi
Chen, Chieh-Hsun
Lan, Cheng-Che Eric
DERMATOLOGY PRACTICAL & CONCEPTUAL, 2024, 14 (03):
[35] Real-world effectiveness and safety of upadacitinib in Japanese patients with atopic dermatitis: a two-centre retrospective study
Kosaka, Keiji
Uchiyama, Akihiko
Ishikawa, Mai
Watanabe, Goichi
Motegi, Sei-ichiro
EUROPEAN JOURNAL OF DERMATOLOGY, 2022, 32 (06) : 800 - 802
[36] Real-world effectiveness and safety of upadacitinib in Japanese patients with atopic dermatitis: a two-centre retrospective study
Keiji Kosaka
Akihiko Uchiyama
Mai Ishikawa
Goichi Watanabe
Sei-ichiro Motegi
European Journal of Dermatology, 2022, 32 : 800 - 802
[37] Long-term drug survival of dupilumab and associated predictors in moderate-to-severe atopic dermatitis: A real-world prospective cohort study
Pezzolo, Elena
Rossi, MariaTeresa
Caroppo, Francesca
Bianchelli, Tommaso
Fortina, Anna Belloni
Giacchetti, Alfredo
Pinton, Piergiacomo Calzavara
Naldi, Luigi
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (06) : E757 - E759
[38] Real-world Data of the new JAK Inhibitors Baricitinib, Upadacitinib, and Abrocitinib in Patients with Atopic Dermatitis
Sollfrank, Lukas
Rechtien, Laura
Sticherling, Michael
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 111 - 112
[39] Practical Use of Upadacitinib in Patients with Severe Atopic Dermatitis in a Real-World Setting: A Systematic Review
Ibba, Luciano
Gargiulo, Luigi
Vignoli, Carlo Alberto
Fiorillo, Giovanni
Valenti, Mario
Costanzo, Antonio
Narcisi, Alessandra
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2024, 17 : 593 - 604
[40] Real-world baseline characteristics and persistence in adult patients initiating tralokinumab in the CorEvitas atopic dermatitis registry
Simpson, Eric
Balu, Sanjeev
Choi, C. Jean
Li, Alvin
Pugach, Oksana
Schneider, Shannon
Silverberg, Jonathan
BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : 89 - 90

← 1 2 3 4 5 →